Literature DB >> 23972359

The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin.

Hidetaka Hamasaki1, Hidekatsu Yanai.   

Abstract

Entities:  

Keywords:  Anagliptin; Angioedema; Dipeptidyl peptidase-IV inhibitor; Type 2 diabetes

Mesh:

Substances:

Year:  2013        PMID: 23972359     DOI: 10.1016/j.ijcard.2013.07.257

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  6 in total

Review 1.  Effects of Sitagliptin on Metabolic Indices and Hormone Levels in Polycystic Ovary Syndrome: a Meta-analysis of Randomized Controlled Trials.

Authors:  Lijuan Zhang; Airong Chen; Jing Lu; Liuliu Ren; Zelin Hu
Journal:  Reprod Sci       Date:  2022-08-12       Impact factor: 2.924

Review 2.  Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance.

Authors:  Ashwani Sharma; Tarun Virmani; Anjali Sharma; Vaishnavi Chhabra; Girish Kumar; Kamla Pathak; Abdulsalam Alhalmi
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-16       Impact factor: 3.249

Review 3.  Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability.

Authors:  Shinya Nishio; Mariko Abe; Hiroyuki Ito
Journal:  Diabetes Metab Syndr Obes       Date:  2015-03-18       Impact factor: 3.168

Review 4.  Angioedema associated with dipeptidyl peptidase-IV inhibitors.

Authors:  Nicoletta Cassano; Eustachio Nettis; Elisabetta Di Leo; Francesca Ambrogio; Gino A Vena; Caterina Foti
Journal:  Clin Mol Allergy       Date:  2021-12-06

5.  Functional Roles for CD26/DPP4 in Mediating Inflammatory Responses of Pulmonary Vascular Endothelial Cells.

Authors:  Yukiko Takahashi; Takeshi Kawasaki; Hironori Sato; Yoshinori Hasegawa; Steven M Dudek; Osamu Ohara; Koichiro Tatsumi; Takuji Suzuki
Journal:  Cells       Date:  2021-12-11       Impact factor: 6.600

6.  Anagliptin prevented interleukin 1β (IL-1β)-induced cellular senescence in vascular smooth muscle cells through increasing the expression of sirtuin1 (SIRT1).

Authors:  Juan Zhao; Xinrong He; Mei Zuo; Xinguo Li; Zhiming Sun
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.